Form 4: Annovis Bio CEO Buys 97,561 Shares

Annovis Bio, Inc.'s President and CEO, Maria-Luisa Maccecchini, acquired 97,561 shares of common stock at $2.05 per share, increasing her direct beneficial ownership to 1,212,020 shares.

Summary

• Maria-Luisa Maccecchini, President & CEO and Director of Annovis Bio, Inc. (ANVS), purchased 97,561 shares of common stock.
• The transaction occurred on October 28, 2025, at a price of $2.05 per share.
• Following this purchase, Maccecchini directly beneficially owns a total of 1,212,020 shares of Annovis Bio common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was a pre-arranged purchase.

Sentiment

Score: 8

Explanation: The significant insider purchase by the CEO and Director indicates strong confidence in the company's prospects, which is generally viewed very positively by the market.

Positives

• Insider buying by the President & CEO and Director signals strong confidence in the company's future prospects.
• The acquisition of 97,561 shares significantly increases the CEO's direct stake in the company, aligning management interests with shareholders.

Future Outlook

NA

Industry Context

Insider buying, especially by a CEO, is often interpreted by the market as a positive signal, suggesting management believes the stock is undervalued or expects positive developments. This is a common occurrence across various industries, including biotechnology, where confidence in pipeline development and future commercialization is crucial.

Stakeholder Impact

• Shareholders may view the CEO's purchase as a strong vote of confidence, potentially leading to increased investor interest and positive sentiment.
• Employees might perceive this as a sign of stability and positive future outlook for the company.

Key Dates

Recommendation

The substantial purchase of common stock by the President & CEO and Director, Maria-Luisa Maccecchini, signals high conviction in Annovis Bio's intrinsic value and future growth trajectory. Insider buying, particularly from top executives, is a powerful indicator of management's belief that the stock is undervalued or that significant positive developments are anticipated. This action suggests a strong alignment of interests between management and shareholders, making it a compelling 'strong buy' signal for seasoned investors.

Keywords

Annovis Bio, ANVS, Insider Buying, Maria-Luisa Maccecchini, CEO Stock Purchase, Form 4, Biotechnology, Pharmaceuticals, Rule 10b5-1